Véronique Lecault
Förmögenhet: 59 M $ per 2026-05-31
Förmögenhet: 59 M $ per 2026-05-31
Dr. Véronique Lecault is a Vice President at Lineage Biosciences, Inc. and a Director & Chief Technology Officer at AbCellera Biologics, Inc. She is on the Board of Directors at Trianni, Inc., AbCellera Australia Pty Ltd. and AbCellera Biologics, Inc. She received her undergraduate degree from the University of Ottawa and a doctorate degree from the University of British Columbia.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-01 | 9 613 674 ( 3,15 % ) | 59 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| ABCELLERA BIOLOGICS INC. | Grundare | 2012-11-08 |
Lineage Biosciences, Inc.
Lineage Biosciences, Inc. Hospital/Nursing ManagementHealth Services Provides medical services | Företagsledare/Principal | 2018-01-01 |
AbCellera Australia Pty Ltd. | Direktör/Styrelseledamot | 2019-09-01 |
Trianni, Inc.
Trianni, Inc. BiotechnologyHealth Technology Develops humanized monoclonal antibody platform | Direktör/Styrelseledamot | 2020-11-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Ottawa
University of Ottawa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trianni, Inc.
Trianni, Inc. BiotechnologyHealth Technology Develops humanized monoclonal antibody platform | Health Technology |
AbCellera Biologics, Inc.
AbCellera Biologics, Inc. BiotechnologyHealth Technology Discovers and develops antibody drugs & therapeutics | Health Technology |
Lineage Biosciences, Inc.
Lineage Biosciences, Inc. Hospital/Nursing ManagementHealth Services Provides medical services | Health Services |
AbCellera Australia Pty Ltd. |
Välj din utgåva
All finansiell information anpassad till den nationella nivån